Schrodinger Cash on Hand 2019-2025 | SDGR

Schrodinger cash on hand from 2019 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Schrodinger Annual Cash on Hand
(Millions of US $)
2024 $367
2023 $469
2022 $456
2021 $579
2020 $643
2019 $86
2018 $84
Schrodinger Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $512
2024-12-31 $367
2024-09-30 $398
2024-06-30 $382
2024-03-31 $436
2023-12-31 $469
2023-09-30 $503
2023-06-30 $554
2023-03-31 $532
2022-12-31 $456
2022-09-30 $479
2022-06-30 $513
2022-03-31 $529
2021-12-31 $579
2021-09-30 $600
2021-06-30 $617
2021-03-31 $649
2020-12-31 $643
2020-09-30 $599
2020-06-30 $285
2020-03-31 $289
2019-12-31 $86
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $84
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.551B $0.208B
Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Hims & Hers Health (HIMS) United States $11.646B 121.00
Doximity (DOCS) United States $11.561B 53.52
Tempus AI (TEM) United States $10.010B 0.00
IRhythm Technologies (IRTC) United States $4.435B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.739B 0.00
Privia Health (PRVA) United States $2.547B 174.08
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.642B 0.00
10x Genomics (TXG) United States $1.535B 0.00
Clover Health Investments (CLOV) United States $1.527B 0.00
Azenta (AZTA) United States $1.475B 68.57
Evolent Health (EVH) United States $1.334B 113.60
Omnicell (OMCL) United States $1.291B 22.78
Claritev (CTEV) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.582B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.450B 0.00
Talkspace (TALK) United States $0.430B 128.50
Outset Medical (OM) United States $0.333B 0.00
TruBridge (TBRG) United States $0.329B 731.00
Health Catalyst (HCAT) United States $0.269B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
Zepp Health (ZEPP) Netherlands $0.139B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.091B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00